Loading...
Loading...
All product recalls associated with Direct Rx.
Total Recalls
36
Past Year
3
Class I (Serious)
0
Most Recent
Mar 2025
Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Failed Impurities/Degradation Specifications: Product failed impurity specifications at the 18-month stability testing.
CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviation: discontinue of stability support for product.
CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.